Get the Stockscreener App
118.11
0.90%
-1.07
After Hours:
118.11
Irhythm Holdings Inc stock is traded at $118.11, with a volume of 536.81K.
It is down -0.90% in the last 24 hours and up +1.12% over the past month.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$119.18
Open:
$119.18
24h Volume:
536.81K
Relative Volume:
0.89
Market Cap:
$3.88B
Revenue:
$787.85M
Net Income/Loss:
$-27.78M
P/E Ratio:
-136.13
EPS:
-0.8676
Net Cash Flow:
$18.75M
1W Performance:
-5.84%
1M Performance:
+1.12%
6M Performance:
-34.56%
1Y Performance:
-13.00%
1-Day Range:
$115.63
$119.18
1-Week Range:
$115.63
$129.97
52-Week Range:
$112.31
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Name
Irhythm Holdings Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
118.11 | 3.92B | 787.85M | -27.78M | 18.75M | -0.8676 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Holdings Inc Stock (IRTC) Latest News
Wall Street analysts predict a 57.21% upside in iRhythm Hldgs (IRTC): Here's what you should know - MSN
iRhythm Holdings CTO Lawrence Lee sells $122,491 in stock - Investing.com
iRhythm (NASDAQ: IRTC) CTO sells 1,014 shares to cover RSU tax obligations - Stock Titan
Wall Street Analysts Predict a 57.21% Upside in IRHYTHM HLDGS (IRTC): Here's What You Should Know - Yahoo Finance UK
iRhythm Holdings, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:IRTC) 2026-05-04 - Seeking Alpha
IRTC Stock Up on Q1 Earnings & Revenue Beat, FY26 Outlook Raised - Zacks Investment Research
US$184: That's What Analysts Think iRhythm Holdings, Inc. (NASDAQ:IRTC) Is Worth After Its Latest Results - Yahoo Finance
iRhythm Technologies (NASDAQ:IRTC) Rating Increased to Buy at Wall Street Zen - MarketBeat
IRhythm Holdings (IRTC) Q1 Loss After Q4 Profit Tests Bullish Profitability Narratives - Sahm
iRhythm Holdings, Inc. Q1 2026 Financial Results and Forward-Looking Statements – Form 10-Q Highlights - Minichart
IRTC Maintained by Canaccord Genuity -- Price Target Lowered to $180 - GuruFocus
IRTC Maintained by JP Morgan -- Price Target Lowered to $175 - GuruFocus
IRTC Maintained by Wells Fargo -- Price Target Lowered to $180 - GuruFocus
JPMorgan Chase & Co. Has Lowered Expectations for iRhythm Technologies (NASDAQ:IRTC) Stock Price - MarketBeat
IRTC Maintained by Needham -- Price Target Raised to $255 - GuruFocus
IRTC Maintained by Evercore ISI Group -- Price Target Lowered to $160 - GuruFocus
iRhythm Holdings, Inc. (IRTC) reports Q1 loss, tops revenue estimates - MSN
Oppenheimer Adjusts Price Target on iRhythm Technologies to $185 From $225, Maintains Outperform Rating - marketscreener.com
iRhythm Technologies (NASDAQ:IRTC) Shares Down 6.5% Following Analyst Downgrade - MarketBeat
Wells Fargo & Company Has Lowered Expectations for iRhythm Technologies (NASDAQ:IRTC) Stock Price - MarketBeat
Q1 2026 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
iRhythm Technologies (NASDAQ:IRTC) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
iRhythm Holdings Inc (IRTC) Q1 2026 Earnings Call Highlights: St - GuruFocus
IRhythm Technologies Q1 2026 earnings preview - MSN
IRTC SWOT Analysis: Growth Potential Amid Financial Challenges R - GuruFocus
iRhythm forecasts 2026 revenue of $875M-$885M while targeting 12%-13% adjusted EBITDA margin - MSN
Transcript : IRhythm Holdings, Inc., Q1 2026 Earnings Call, Apr 30, 2026 - marketscreener.com
Why The Narrative Around iRhythm Holdings (IRTC) Is Shifting After Valuation And DOJ Updates - Yahoo Finance
iRhythm Technologies (NASDAQ:IRTC) Announces Quarterly Earnings Results - MarketBeat
Is iRhythm Holdings (IRTC) 23.9% Undervalued After Q1 2026 Beat? - GuruFocus
iRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
IRhythm Q1 Adjusted Loss Narrows, Revenue Rises - marketscreener.com
(IRTC) iRhythm Expects 2026 Revenue Range $875 Million-$885 Million, vs. FactSet Est of $876.2 Million - marketscreener.com
iRhythm Holdings (NASDAQ: IRTC) grows Q1 2026 sales and turns Adjusted EBITDA positive - Stock Titan
iRhythm Holdings Inc (NASDAQ:IRTC) Beats Q1 Estimates, Raises Guidance, Shares Surge - ChartMill
iRhythm (NASDAQ:IRTC) Posts Better-Than-Expected Sales In Q1 CY2026 - Barchart.com
Earnings Flash (IRTC) iRhythm Holdings, Inc. Posts Q1 Adjusted Loss $0.35 per Share, vs. FactSet Est of $-0.62 - marketscreener.com
Earnings Flash (IRTC) iRhythm Holdings, Inc. Reports Q1 Revenue $199.4M, vs. FactSet Est of $194.1M - marketscreener.com
iRhythm Holdings Announces First Quarter 2026 Financial Results - The Manila Times
Revenue jumps at iRhythm (NASDAQ: IRTC) as Q1 2026 loss shrinks - Stock Titan
IRhythm Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Here's why you should retain IRTC stock in your portfolio for now - MSN
iRhythm (IRTC) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
IRTC Q1'26 Earnings: EPS estimate is (0.66) USD - TradingView
iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference - The Manila Times
IRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference - marketscreener.com
May 13 webcast: iRhythm executives speak at BofA health event - Stock Titan
Vanguard holds 1.82M IRhythm shares (NYSE: IRTC) — 5.64% stake - Stock Titan
Is It Time To Reassess iRhythm Holdings (IRTC) After Recent Share Price Rebound - Yahoo Finance
iRhythm Technologies $IRTC Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Why iRhythm (IRTC) Stock Is Up Today - Yahoo Finance
Irhythm Holdings Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):